Intrathecal analgesia.
Since the first use of intrathecal (IT) drug infusion systems in the early 1980s, these delivery systems have undergone numerous revisions making them more tolerable, easier to program, and longer lasting. Concurrent with technological advances, the indications for IT pump placement have also been continuously evolving, to the point where the most common indication is now noncancer pain. This article provides an evidence-based review of the indications, efficacy, and complications of IT drug therapy for the most commonly administered spinal analgesics.
Cohen
Steven P
SP
Pain Management Division, Department of Anesthesiology, Johns Hopkins School of Medicine, 550 North Broadway, Suite 301, Baltimore, MD 21205, USA. scohen40@jhmi.edu
Dragovich
Anthony
A
D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D000779:Anesthetics, Local; D002121:Calcium Channel Blockers; D018755:GABA Agonists; D006801:Humans; D015918:Infusion Pumps, Implantable; D007278:Injections, Spinal / Q000379:methods*; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D011957:Receptors, Opioid / Q000187:drug effects; D013997:Time Factors
D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D002121:Calcium Channel Blockers; D018755:GABA Agonists; D016194:Receptors, N-Methyl-D-Aspartate; D011957:Receptors, Opioid